`
Monday, 26 June 2017

Drug Discovery News

  • Gilead's cancer drug under FDA scrutiny

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2016

    Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) due to incoming reports of an increased rate of adverse events, includi...Read more

  • CytRx gets FDA nod Aldoxorubicin cancer trial

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 10 May, 2013

    Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the US FDA under a special protocol assessment (SPA) for a global pivotal ...Read more

  • China's Zai Lab raises $100mn

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016

    Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B financing from a group of investors led by Advantech Capital and included ...Read more

  • CSL files marketing plea for Privigen in Europe

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012

    Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) for the use of Privigen (immune globulin intravenous [human], 10 perce...Read more

  • Orient, NanoCarrier sign deal for Nanoplatin trial

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2012

    Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreement for conducting registration trials of Nanoplatin in Taiwan, Singap...Read more

  • Novogen's ovarian cancer drug set for trials in H1 2016

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016

    US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Cantrixil (TRXE-002-1), its lead superbenzopyran (SBP) molecule, which ...Read more

  • Japanese scientist inch closer to Toxoplasma vaccine discovery

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2015

    Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer. Pregnant women ...Read more

  • Australia's Gordagen forays into Japan with Matsumoto's support

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2016

    Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has entered into a collaborative product development agreement with Japa...Read more

  • Takeda gets NDA approval for VAXEM Hib vaccine in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2016

    Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approved the New Drug Application (NDA) for a conjugate vaccine to prevent i...Read more

  • Aspirin use increases risk of age-related eye disease

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013

    Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WMI), a close affiliate of the University of Sydney, have found that re...Read more

  • Systems Toxicology Computational Challenge explores toxicant prediction

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2016

    Singapore: The Systems Toxicology Computational Challenge run under the sbv IMPROVER umbrella, a crowdsourcing initiative led and funded by Philip Morris International which is designed to ...Read more

  • University of Dundee, Ono Pharma to collaborate on drug research

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2016

    A Japanese delegation will initiate a partnership with University of Dundee seeking to develop new treatments for inflammatory diseases. Scientists and executives from Ono, Japan's oldest p...Read more

  • FDA approves Eli Lilly's combination drug for metastatic colorectal cancer

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2015

    Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Folfiri, chemotherapy regimen for colorectal cancer, for the treatment ...Read more

  • Scientists use tiniest human protein to heal heart

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013

    Singapore: Scientists at A*Star's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially ...Read more

  • Asia's lung cancer burden

    Drug Discovery |  Analysis | By Amrita Tejasvi | 0 Comment | 08 Apr, 2016

    Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to oncology specialists' analysis, 85 percent of the lung cancer patien...Read more

  • BMS uses Santaris platform for drug discovery

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 18 Apr, 2013

    Singapore: Santaris Pharma, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, has formed strategic alliance with Br...Read more

  • Mitsubishi Tanabe to manufacture diabetes drug Tenelia

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012

    Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibitor Tenelia 20mg tablets (Teneligliptin hydrobromide hydrate) in Japa...Read more

  • Wockhardt increases investment in R&D

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2015

    Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plans to further strengthen its research and development capabilities and...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls